Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Qualcomm to issue warrant to Amazon for up to 25M shares
- Trump says Canada's Bombardier must build jets in US or lose market access
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Evercore ISI Positive on Estee Lauder (EL) Following Earnings
February 5, 2024 8:11 AM ESTEvercore ISI analyst Robert Ottenstein reiterated an Outperform rating and $145.00 price target on Estee Lauder (NYSE: EL).
The analyst comments "Estees 2Q EPS F24 of $0.88 represented a $0.33 upside to consensus $.55, driven by signs of stabilization in the European division, where global travel retail operates sales are still declining... More
Citi on Estee Lauder (EL): 'We expect the new restructuring plan...to drive a positive reaction today'
February 5, 2024 7:40 AM ESTCiti analyst Filippo Falorni reiterated a Neutral rating and $140.00 price target on Estee Lauder (NYSE: EL).
The analyst comments "As we highlighted in our preview, F2Q24 results were pressured by continued headwinds in Asia Pac TR & Mainland China but... More
Goldman Sachs on Estee Lauder (EL) Post Earnings: 'we expect the stock to trade higher'
February 5, 2024 7:38 AM ESTGoldman Sachs analyst Jason English reiterated a Buy rating and $141.00 price target on Estee Lauder (NYSE: EL)
The analyst comments "EL reported mixed results with a sharp sequential improvement in gross margin driving an EPS beat that was coupled with revenue that was... More
